← FDA Drug Approvals (Drugs@FDA)

LOPINAVIR AND RITONAVIR

NDA · New Drug Application · Sponsor: CIPLA LTD · Approved 2015-05-21

Drug application

FDA Application #

NDA205425

Application type

New Drug Application

Brand name

LOPINAVIR AND RITONAVIR

Generic name

Lopinavir

Active ingredients

LOPINAVIR; RITONAVIR

Dosage form

PELLETS

Route

ORAL

Marketing status

None (Tentative Approval)

Sponsor

CIPLA LTD

First approval

2015-05-21

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown